Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 5Thoracic 3Breast 2Sarcoma 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Head and Neck Neoplasms 1284Squamous Cell Carcinoma of Head and Neck 707Thyroid Neoplasms 297Carcinoma, Non-Small-Cell Lung 180Mouth Neoplasms 177Neoplasms 173Breast Neoplasms 172Lung Neoplasms 152Salivary Gland Neoplasms 143Oropharyngeal Neoplasms 132Nasopharyngeal Carcinoma 128Melanoma 117Carcinoma, Squamous Cell 116Colorectal Neoplasms 112Laryngeal Neoplasms 108Ovarian Neoplasms 102Esophageal Neoplasms 100Nasopharyngeal Neoplasms 96Prostatic Neoplasms 92Pancreatic Neoplasms 92Stomach Neoplasms 88Uterine Cervical Neoplasms 86Neoplasm Metastasis 86Thyroid Cancer, Papillary 78Carcinoma, Renal Cell 78Urinary Bladder Neoplasms 74Thyroid Nodule 68Sarcoma 65Colonic Neoplasms 63Small Cell Lung Carcinoma 62

Interventions

Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Nervous System Neoplasms × Head & Neck × Clear all
NCT00437372 2025-05-02

Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

Thomas Jefferson University

Phase 1 Completed
39 enrolled
GynecologicHead & NeckThoracic

Head and Neck Neoplasms, Neoplasms, Nervous System Neoplasms, Pelvic Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡